Sri Lanka approves Pfizer coronavirus vaccine for emergency use

Sri Lanka is the first country in South Asia to approve the Pfizer vaccine

Pfizer Vaccine, Coronavirus vaccine
Photo: Shutterstock
Reuters COLOMBO
1 min read Last Updated : May 08 2021 | 3:07 PM IST

Sri Lanka on Saturday approved Pfizer's COVID-19 vaccine for emergency use in Sri Lanka, as the island nation battles a third wave of the virus, while suffering a restricted supply of vaccines from neighboring India.

Dr. Sudharshani Fernandopulle, the minister overseeing the fight against the epidemic, said in a statement the government would order 5 million doses of the Pfizer vaccine.

Sri Lanka is seeking to secure other vaccines as the Serum Institute of India, the world's largest vaccine manufacturer, has suspended the delivery of AstraZeneca's Covishield vaccine due to spiraling coronavirus infections in India.

Sri Lanka is the first country in South Asia to approve the Pfizer vaccine. It has also approved Russia's Sputnik and China's Sinopharm vaccines for emergency use.

The island nation reported 1,914 new cases and 19 deaths in the past 24 hours, according to federal health data, and its total number of active cases is higher than any point since the pandemic began. Infections surged after crowded celebrations for traditional New Year last month.

 

(Reporting by Waruna Karunatilake in Colombo; Writing by Alasdair Pal)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirussri lankaPfizer

First Published: May 08 2021 | 3:01 PM IST

Next Story